0001209191-18-026950.txt : 20180430 0001209191-18-026950.hdr.sgml : 20180430 20180430205927 ACCESSION NUMBER: 0001209191-18-026950 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180426 FILED AS OF DATE: 20180430 DATE AS OF CHANGE: 20180430 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Paul David C CENTRAL INDEX KEY: 0001555391 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35621 FILM NUMBER: 18792715 MAIL ADDRESS: STREET 1: C/O GLOBUS MEDICAL, INC. STREET 2: 2560 GENERAL ARMISTEAD AVENUE CITY: AUDUBON STATE: PA ZIP: 19403 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GLOBUS MEDICAL INC CENTRAL INDEX KEY: 0001237831 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 043744954 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2560 GENERAL ARMISTEAD AVENUE CITY: AUDUBON STATE: PA ZIP: 19403 BUSINESS PHONE: 610-930-1800 MAIL ADDRESS: STREET 1: 2560 GENERAL ARMISTEAD AVENUE CITY: AUDUBON STATE: PA ZIP: 19403 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-04-26 0 0001237831 GLOBUS MEDICAL INC GMED 0001555391 Paul David C VALLEY FORGE BUSINESS CENTER 2560 GENERAL ARMISTEAD AVENUE AUDUBON PA 19403 1 1 1 0 Executive Chairman Class A Common Stock 2018-04-26 4 M 0 18461 4.88 A 1096461 D Class A Common Stock 2018-04-26 4 S 0 18461 51.8068 D 1078000 D Class A Common Stock 2018-04-26 4 M 0 18461 11.8625 A 1096461 D Class A Common Stock 2018-04-26 4 S 0 18461 51.8068 D 1078000 D Class A Common Stock 2018-04-26 4 M 0 18461 10.66 A 1096461 D Class A Common Stock 2018-04-26 4 S 0 18461 51.8068 D 1078000 D Class A Common Stock 2018-04-26 4 M 0 15000 15.34 A 1093000 D Class A Common Stock 2018-04-26 4 S 0 15000 51.8068 D 1078000 D Class A Common Stock 2018-04-26 4 M 0 48000 13.04 A 1126000 D Class A Common Stock 2018-04-26 4 S 0 48000 51.8068 D 1078000 D Class A Common Stock 2018-04-26 4 M 0 60000 23.95 A 1138000 D Class A Common Stock 2018-04-26 4 S 0 60000 51.8068 D 1078000 D Class A Common Stock 2018-04-26 4 M 0 98958 24.10 A 1176958 D Class A Common Stock 2018-04-26 4 S 0 98958 51.8068 D 1078000 D Class A Common Stock 2018-04-26 4 M 0 40625 25.52 A 1118625 D Class A Common Stock 2018-04-26 4 S 0 40625 51.8068 D 1078000 D Class A Common Stock 2018-04-26 4 M 0 43750 26.27 A 1121750 D Class A Common Stock 2018-04-26 4 S 0 43750 51.8068 D 1078000 D Class A Common Stock 2018-04-26 4 S 0 363284 51.8068 D 714716 D Class A Common Stock 2018-04-27 4 S 0 29066 51.7831 D 685650 D Class A Common Stock 2018-04-30 4 S 0 72938 51.8053 D 612712 D Stock Option (Right to Buy Class A Common Stock) 4.88 2018-04-26 4 M 0 18461 0.00 D 2019-08-06 Class A Common Stock 18461 0 D Stock Option (Right to Buy Class A Common Stock) 11.8625 2018-04-26 4 M 0 18461 0.00 D 2020-06-16 Class A Common Stock 18461 0 D Stock Option (Right to Buy Class A Common Stock) 10.66 2018-04-26 4 M 0 18461 0.00 D 2021-10-27 Class A Common Stock 18461 0 D Stock Option (Right to Buy Class A Common Stock) 15.34 2018-04-26 4 M 0 15000 0.00 D 2022-08-29 Class A Common Stock 15000 0 D Stock Option (Right to Buy Class A Common Stock) 13.04 2018-04-26 4 M 0 48000 0.00 D 2023-01-24 Class A Common Stock 48000 0 D Stock Option (Right to Buy Class A Common Stock) 23.95 2018-04-26 4 M 0 60000 0.00 D 2024-01-23 Class A Common Stock 60000 0 D Stock Option (Right to Buy Class A Common Stock) 24.10 2018-04-26 4 M 0 98958 0.00 D 2025-01-20 Class A Common Stock 98958 26042 D Stock Option (Right to Buy Class A Common Stock) 25.52 2018-04-26 4 M 0 40625 0.00 D 2026-01-25 Class A Common Stock 40625 34375 D Stock Option (Right to Buy Class A Common Stock) 26.27 2018-04-26 4 M 0 43750 0.00 D 2027-01-30 Class A Common Stock 43750 106250 D This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.80 to $52.155, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.75 to $51.8558, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.75 to $51.935, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4. These options were granted on August 6, 2009, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2010, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. These options were granted on June 16, 2010, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2011, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. These options were granted on October 27, 2011, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2012, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. These options were granted on August 29, 2012, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2013, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. These options were granted on January 24, 2013, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2014, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. These options were granted on January 23, 2014, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2015, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. These options were granted on January 20, 2015, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2016, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. These options were granted on January 25, 2016, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2017, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. These options were granted on January 30, 2017, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2018, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months /s/ Eric I. Schwartz, Attorney-in-Fact 2018-04-30